step 1 trial semaglutide 2.4 mg weight loss nejm 2021 SURPASS-2 (NEJM 2021) was the definitive head-to-head: tirzepatide vs 1.0 (the maximum approved T2DM dose) in 1,879 patients with type 2 diabetes. All three tirzepatide doses produced superior HbA1c reductions Tirzepatide vs Semaglutide Compared |

Energetic mitochondrial failing in vitiligo and possible rescue by cardiolipin

In this study, the weight loss response to semaglutide differed between postmenopausal women with and without HT use, note study authors

The Dark Side of Iron: The Relationship between Iron, Inflammation and Gut Microbiota in Selected Diseases Associated with Iron Deficiency Anaemia-A Narrative Review

Check out these related posts

Tirzepatide: Dual-Action Weight Loss Therapy Tirzepatide, found in Zepbound, works on two hormone receptors: GLP-1 (appetite and satiety) GIP (glucose-dependent insulinotropic polypeptide), which plays a role in insulin sensitivity and fat metabolism This dual-action approach often leads to: Greater appetite suppression Enhanced effects on blood sugar regulation Higher average weight-loss outcomes in many patients Because tirzepatide influences more than one metabolic pathway, it may be particularly beneficial for individuals with insulin resistance or metabolic syndrome